UBS Group’s Nu Skin NUS Stock Holding History

UBS Group’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,600	Closed	-$172K	–	8064
2019 Q1	$172K	Buy	+3,600	New	+$218K	﹤0.01%	4710
2017 Q4	–	Sell	-40,000	Closed	-$2.46M	–	8012
2017 Q3	$2.46M	Sell	40,000 -40,000	-50%	-$2.46M	﹤0.01%	2942
2017 Q2	$5.03M	Hold	80,000	–	–	﹤0.01%	2146
2017 Q1	$4.44M	Buy	80,000 +40,000	+100%	+$2.06M	﹤0.01%	2184
2016 Q4	$1.91M	Hold	40,000	–	–	﹤0.01%	2951
2016 Q3	$2.59M	Buy	+40,000	New	+$2.25M	﹤0.01%	2612
2016 Q1	–	Sell	-200	Closed	-$8K	–	7999
2015 Q4	$8K	Hold	200	–	–	﹤0.01%	7432
2015 Q3	$8K	Hold	200	–	–	﹤0.01%	7411
2015 Q2	$9K	Sell	200 -200,000	-100%	-$10.8M	﹤0.01%	7541
2015 Q1	$12.1M	Buy	200,200 +145,000	+263%	+$7.38M	0.01%	1326
2014 Q4	$2.41M	Buy	+55,200	New	+$2.44M	﹤0.01%	2718

Other funds holding NUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

UBS Group's NUS Position: Q2 2026 in Review

UBS Group reduced its Nu Skin (NUS) stake by 48% in Q2 2026, selling an estimated $725K and leaving 122,629 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #6072.

UBS Group first reported a position in NUS in Q4 2014 and has held it in 47 quarters since. The position peaked at $19M in Q4 2021. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

UBS Group held 122,629 shares of Nu Skin worth $647K as of Q2 2026.
UBS Group sold 113,396 Nu Skin shares in Q2 2026, an estimated $725K.
Nu Skin made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6072 holding.
UBS Group first reported a position in Nu Skin in Q4 2014 and has held it in 47 quarters since.
UBS Group's Nu Skin position peaked at $19M in Q4 2021.
162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.